Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk?
This is not the latest version of this item. The latest version can be found here.

Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk?

Thumbnail Image
Download
Name

10549_2018_5117_ReferencePDF.pdf

Size

56.95 KB

Format

Adobe PDF

Checksum (MD5)

f3ff43e0a2b3f87c8d6ef10a9be68fc0

Download all files submitted through automated deposit
art_610370000220260781.zip (55.62 KB)
Author(s)
Coopey, Suzanne B
•
Kartal, Kinyas
•
Li, Clara
•
Yala, Adam
•
Barzilay, Regina
•
Faulkner, Heather R
•
King, Tari A
•
Acevedo, Francisco
•
Garber, Judy E
•
Guidi, Anthony J
more
Date Issued
January 21, 2019
Publisher
Springer US
Version
Author's final manuscript
Abstract
Abstract Purpose Atypical ductal hyperplasia (ADH) significantly increases the risk of breast cancer in women. However, little is known about the implications of ADH in men. Methods Review of 932 males with breast pathology was performed to identify cases of ADH. Patients were excluded if ADH was upgraded to cancer on excision, or if they had contralateral breast cancer. Cases were reviewed to determine whether any male with ADH developed breast cancer. Results Nineteen males were diagnosed with ADH from June 2003 to September 2018. All had gynecomastia. Surgical procedure was mastectomy in 8 patients and excision/reduction in 11. One patient had their nipple areola complex removed, and 1 required a free nipple graft. Median patient age at ADH diagnosis was 25 years (range 18–72 years). Of the 14 patients with bilateral gynecomastia, 10 had bilateral ADH and 4 had unilateral. Five cases of ADH were described as severe, bordering on ductal carcinoma in situ. No patient reported a family history of breast cancer. No patient took tamoxifen. At a mean follow-up of 75 months (range 4–185 months), no patient developed breast cancer. Conclusion Our study is the first to provide follow-up information for males with ADH. With 6 years of mean follow-up, no male in our series has developed breast cancer. This suggests that either ADH in men does not pose the same risk as ADH in women or that surgical excision of symptomatic gynecomastia in men effectively reduces the risk of breast cancer.
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
http://creativecommons.org/licenses/by-nc-sa/4.0/
Persistent DSpace Link
https://hdl.handle.net/1721.1/131908
DOI of Published Version
https://doi.org/10.1007/s10549-018-05117-4
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.